Chen, Pei-Chun <br/><br/>
Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Apr 2012 
 - 1996-2003 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-355X 
<br/><br/><label>Standard No.: </label>10.1016/j.ijrobp.2011.02.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Chemoradiotherapy--methods<br/>Chromosomes, Human, Pair 2--genetics<br/>Cisplatin--administration & dosage<br/>Disease Progression<br/>Esophageal Neoplasms--genetics<br/>Esophagectomy<br/>Fluorouracil--administration & dosage<br/>Genome-Wide Association Study--methods<br/>Humans<br/>Linkage Disequilibrium--genetics<br/>Male<br/>Middle Aged<br/>Models, Genetic<br/>Polymorphism, Single Nucleotide<br/>Prospective Studies<br/>Radiotherapy Dosage<br/>Remission Induction--methods<br/>Taiwan<br/>Treatment Outcome